Literature DB >> 21927031

E6AP is required for replicative and oncogene-induced senescence in mouse embryo fibroblasts.

Y Levav-Cohen1, K Wolyniec, O Alsheich-Bartok, A-L Chan, S J Woods, Y-H Jiang, S Haupt, Y Haupt.   

Abstract

Cellular senescence is important for the maintenance of tissue homeostasis, and has recently been shown to pose a natural barrier to tumorigenesis. The E3 ubiquitin ligase, E6AP, has been linked to a number of protein regulators of the cell cycle as well as the cellular stress response. We therefore explored the role of E6AP in the cellular response to stress. We found that mouse embryo fibroblasts (MEFs) lacking E6AP escape replicative senescence, as well as Ras-induced senescence associated with impaired markers. E6AP-deficient MEFs exhibit a range of transformed phenotypes: these include the ability to grow under stress conditions (such as low serum and DNA damage), enhanced proliferation, anchorage independent growth and enhanced growth of xenografts in mice. The transformed phenotype of E6AP-deficient MEFs is associated with lower basal and stress-induced accumulation of p53. Overall, our study implicates E6AP as an important regulator of the cellular response to stress, in particular through the regulation of replicative and oncogene-induced senescence.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21927031     DOI: 10.1038/onc.2011.402

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  7 in total

1.  Proteotranscriptomic Measurements of E6-Associated Protein (E6AP) Targets in DU145 Prostate Cancer Cells.

Authors:  Twishi Gulati; Cheng Huang; Franco Caramia; Dinesh Raghu; Piotr J Paul; Robert J A Goode; Simon P Keam; Scott G Williams; Sue Haupt; Oded Kleifeld; Ralf B Schittenhelm; Cristina Gamell; Ygal Haupt
Journal:  Mol Cell Proteomics       Date:  2018-02-20       Impact factor: 5.911

2.  Restoration of tumor suppression in prostate cancer by targeting the E3 ligase E6AP.

Authors:  P J Paul; D Raghu; A-L Chan; T Gulati; L Lambeth; E Takano; M J Herold; J Hagekyriakou; R L Vessella; C Fedele; M Shackleton; E D Williams; S Fox; S Williams; S Haupt; C Gamell; Y Haupt
Journal:  Oncogene       Date:  2016-09-19       Impact factor: 9.867

3.  Uncovering a novel pathway for p16 silencing: Therapeutic implications for lung cancer.

Authors:  C Gamell; T Gulati; B Solomon; S Haupt; Y Haupt
Journal:  Mol Cell Oncol       Date:  2017-03-07

4.  Identifying the ubiquitination targets of E6AP by orthogonal ubiquitin transfer.

Authors:  Yiyang Wang; Xianpeng Liu; Li Zhou; Duc Duong; Karan Bhuripanyo; Bo Zhao; Han Zhou; Ruochuan Liu; Yingtao Bi; Hiroaki Kiyokawa; Jun Yin
Journal:  Nat Commun       Date:  2017-12-20       Impact factor: 14.919

5.  Novel Insights into the Role of UBE3A in Regulating Apoptosis and Proliferation.

Authors:  Lilach Simchi; Julia Panov; Olla Morsy; Yonatan Feuermann; Hanoch Kaphzan
Journal:  J Clin Med       Date:  2020-05-22       Impact factor: 4.241

6.  Bioinformatics Analyses of the Transcriptome Reveal Ube3a-Dependent Effects on Mitochondrial-Related Pathways.

Authors:  Julia Panov; Lilach Simchi; Yonatan Feuermann; Hanoch Kaphzan
Journal:  Int J Mol Sci       Date:  2020-06-10       Impact factor: 5.923

7.  Induction of E6AP by microRNA-302c dysregulation inhibits TGF-β-dependent fibrogenesis in hepatic stellate cells.

Authors:  Ji Young Kim; Kyu Min Kim; Ji Hye Yang; Sam Seok Cho; Seung Jung Kim; Su Jung Park; Sang-Gun Ahn; Gum Hwa Lee; Jin Won Yang; Sung Chul Lim; Keon Wook Kang; Sung Hwan Ki
Journal:  Sci Rep       Date:  2020-01-16       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.